NLRP3 and asthma: Specifically, NLRP3 levels in induced sputum are significantly elevated in children with asthma, with further elevation observed in those with moderate-to-severe disease, suggesting that induced sputum NLRP3 may serve as a potential biomarker for assessing asthma severity (Li & Liu, 2024).